Correction to “Adult interest in using a hypothetical modified risk tobacco product: findings from wave 1 of the Population Assessment of Tobacco and Health Study (2013–14)”(Addiction., (2018), 113, (113–124), 10.1111/add.13952);Adult interest in using a hypothetical modified risk tobacco product: findings from wave 1 of the Population Assessment of Tobacco and Health Study (2013–14)

Addiction

Volumn 113, Issue 1, 2018, Pages 113-124

  Pearson, Jennifer L ^a,b   Johnson, Amanda L ^a   Johnson, Sarah E ^c   Stanton, Cassandra A ^d,e   Villanti, Andrea C ^a,b   Niaura, Raymond S ^a,b   Glasser, Allison M ^a   Wang, Baoguang ^c   Abrams, David B ^a,b,e   Cummings, K Michael ^f   Hyland, Andrew ^g  

^a Legacy   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c CENTER FOR TOBACCO PRODUCTS   (United States)

^d WESTAT   (United States)

^e GEORGETOWN UNIVERSITY   (United States)

^f MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^g ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Epidemiology; Food and Drug Administration; modified risk tobacco products; Population Assessment of Tobacco and Health; public health; regulation; study; tobacco

Indexed keywords

ADOLESCENT; ADULT; AGED; ATTITUDE TO HEALTH; ELECTRONIC CIGARETTE; EPIDEMIOLOGY; FEMALE; HUMAN; MALE; MIDDLE AGED; RISK REDUCTION; SMOKING; TOBACCO; TOBACCO USE; UNITED STATES; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ATTITUDE TO HEALTH; ELECTRONIC NICOTINE DELIVERY SYSTEMS; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK REDUCTION BEHAVIOR; SMOKING; TOBACCO PRODUCTS; TOBACCO USE; UNITED STATES; YOUNG ADULT;

EID: 85028918365     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/add.16605     Document Type: Erratum

References (42)

1. Cervellati F., Muresan X. M., Sticozzi C., Gambari R., Montagner G., Forman H. J. et al. Comparative effects between electronic and cigarette smoke in human keratinocytes and epithelial lung cells. Toxicol In Vitro 2014; 28: 999–1005.
2. Coggins C. R., Ballantyne M., Curvall M., Rutqvist L. E. The in vitro toxicology of Swedish snus. Crit Rev Toxicol 2012; 42: 304–313.
3. Farsalinos K. E., Romagna G., Allifranchini E., Ripamonti E., Bocchietto E., Todeschi S. et al. Comparison of the cytotoxic potential of cigarette smoke and electronic cigarette vapour extract on cultured myocardial cells. Int J Environ Res Public Health 2013; 10: 5146–5162.
4. Gartner C. E., Hall W. D., Vos T., Bertram M. Y., Wallace A. L., Lim S. S. Assessment of Swedish snus for tobacco harm reduction: an epidemiological modelling study. Lancet 2007; 369: 2010–2014.
5. Hansson J., Galanti M. R., Hergens M. P., Fredlund P., Ahlbom A., Alfredsson L. et al. Snus (Swedish smokeless tobacco) use and risk of stroke: pooled analyses of incidence and survival. J Intern Med 2014; 276: 87–95.
6. Hansson J., Pedersen N. L., Galanti M. R., Andersson T., Ahlbom A., Hallqvist J. et al. Use of snus and risk for cardiovascular disease: results from the Swedish twin registry. J Intern Med 2009; 265: 717–724.
7. Hecht S. S., Carmella S. G., Kotandeniya D., Pillsbury M. E., Chen M., Ransom B. W. et al. Evaluation of toxicant and carcinogen metabolites in the urine of e-cigarette users versus cigarette smokers. Nicotine Tob Res 2015; 17: 704–709.
8. Misra M., Leverette R. D., Cooper B. T., Bennett M. B., Brown S. E. Comparative in vitro toxicity profile of electronic and tobacco cigarettes, smokeless tobacco and nicotine replacement therapy products: E-liquids, extracts and collected aerosols. Int J Environ Res Public Health 2014; 11: 11325–11347.
9. Nordenvall C., Nilsson P. J., Ye W., Andersson T. M., Nyren O. Tobacco use and cancer survival: a cohort study of 40,230 Swedish male construction workers with incident cancer. Int J Cancer 2013; 132: 155–161.
10. Yan X. S., D'Ruiz C. Effects of using electronic cigarettes on nicotine delivery and cardiovascular function in comparison with regular cigarettes. Regul Toxicol Pharmacol 2015; 71: 24–34.
11. House of Representatives (H.R). 1256-111th congress: Family Smoking Prevention and Tobacco Control Act 2012. Washington, DC: United States Congress; 2009.
12. Parascandola M., Hurd A. L., Augustson E. Consumer awareness and attitudes related to new potential reduced-exposure tobacco products. Am J Health Behav 2008; 32: 431–437.
13. Shaikh R. A., Siahpush M., Singh G. K. Socioeconomic, demographic and smoking-related correlates of the use of potentially reduced exposure to tobacco products in a national sample. Tob Control 2014; 23: 353–358.
14. O'Connor R. J., Norton K. J., Bansal-Travers M., Mahoney M. C., Cummings K. M., Borland R. US smokers’ reactions to a brief trial of oral nicotine products. Harm Reduct J 2011; 8: 1.
15. Agaku I. T., King B. A., Husten C. G., Bunnell R., Ambrose B. K., Hu S. S. et al. Tobacco product use among adults—United States, 2012–2013. Morb Mortal Wkly Rep 2014; 63: 542–547.
16. Biener L., Bogen K., Connolly G. Impact of corrective health information on consumers’ perceptions of ‘reduced exposure’ tobacco products. Tob Control 2007; 16: 306–311.
17. Cummings K. M., Hyland A., Bansal M. A., Giovino G. A. What do Marlboro lights smokers know about low-tar cigarettes? Nicotine Tob Res 2004; 6: S323–S332.
18. Shiffman S., Pillitteri J. L., Burton S. L., Rohay J. M., Gitchell J. G. Smokers’ beliefs about ‘light’ and ‘ultra light’ cigarettes. Tob Control 2001; 10: i17–i23.
19. Kozlowski L., Goldberg M., Yost B., White E., Sweeney C., Pillitteri J. Smokers’ misperceptions of light and ultra-light cigarettes may keep them smoking. Am J Prev Med 1998; 15: 9–16.
20. Shiffman S., Pillitteri J. L., Burton S. L., Di Marino M. E. Smoker and ex-smoker reactions to cigarettes claiming reduced risk. Tob Control 2004; 13: 78–84.
21. Parascandola M., Augustson E., O'Connell M. E., Marcus S. Consumer awareness and attitudes related to new potential reduced-exposure tobacco product brands. Nicotine Tob Res 2009; 11: 886–895.
22. Parascandola M., Augustson E., Rose A. Characteristics of current and recent former smokers associated with the use of new potential reduced-exposure tobacco products. Nicotine Tob Res 2009; 11: 1431–1438.
23. US Department of Health and Human Services. The Health Consequences of Smoking: 50 Years of Progress. A Report of the Surgeon General. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2014.
24. Cobb C. O., Villanti A. C., Graham A. L., Glasser A. M., Rath J. M., Stanton C. A. et al. Markov modeling to estimate the population impact of emerging tobacco products: a proof-of-concept study. Tob Regul Sci 2015; 1: 129–141.
25. United States Department of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse, and United States Department of Health and Human Services, Food and Drug Administration, Center for Tobacco Products. Population Assessment of Tobacco and Health (PATH) Study [United States] Restricted-Use Files. ICPSR36231. Ann Arbor, MI: Inter-university Consortium for Political and Social Research [distributor] 2016-05-24. https://doi.org/10.3886/ICPSR36231.
26. Hyland A., Ambrose B. K., Conway K. P., Borek N., Lambert E., Carusi C. et al. Design and methods of the population assessment of tobacco and health (PATH) study. Tob Control 2016; https://doi.org/10.1136/tobaccocontrol-2016-052934.
27. Haberstick B. C., Timberlake D., Ehringer M. A., Lessem J. M., Hopfer C. J., Smolen A. et al. Genes, time to first cigarette and nicotine dependence in a general population sample of young adults. Addiction 2007; 102: 655–665.
28. Heatherton T. F., Kozlowski L. T., Frecker R. C., Rickert W., Robinson J. Measuring the heaviness of smoking: using self-reported time to the first cigarette of the day and number of cigarettes smoked per day. Br J Addict 1989; 84: 791–799.
29. Degenhardt L., Hall W. The relationship between tobacco use, substance-use disorders and mental health: results from the National Survey of Mental Health and Well-Being. Nicotine Tob Res 2001; 3: 225–234.
30. Kalman D., Morissette S. B., George T. P. Co-morbidity of smoking in patients with psychiatric and substance use disorders. Am J Addict 2005; 14: 106–123.
31. Dennis M. L., Chan Y. F., Funk R. R. Development and validation of the GAIN short screener (GSS) for internalizing, externalizing and substance use disorders and crime/violence problems among adolescents and adults. Am J Addict 2006; 15: 80–91.
32. Zou G. A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol 2004; 159: 702–706.
33. Delnevo C. D., Giovenco D. P., Steinberg M. B., Villanti A. C., Pearson J. L., Niaura R. S. et al. Patterns of electronic cigarette use among adults in the United States. Nicotine Tob Res 2016; 18: 715–719.
34. Berlin I., Covey L. S. Pre-cessation depressive mood predicts failure to quit smoking: the role of coping and personality traits. Addiction 2006; 101: 1814–1821.
35. Haukkala A., Uutela A., Vartiainen E., McAlister A., Knekt P. Depression and smoking cessation: the role of motivation and self-efficacy. Addict Behav 2000; 25: 311–316.
36. McClave A. K., Dube S. R., Strine T. W., Kroenke K., Caraballo R. S., Mokdad A. H. Associations between smoking cessation and anxiety and depression among U.S. adults. Addict Behav 2009; 34: 491–497.
37. Agaku I. T., King B. A., Dube S. R. Centers for Disease Control and Prevention. Current cigarette smoking among adults—United States, 2005–2012. Morb Mortal Wkly Rep 2014; 63: 29–34.
38. Piasecki T. Relapse to smoking. Clin Psychol Rev 2006; 26: 196–215.
39. Adkison S. E., O'Connor R. J., Bansal-Travers M., Hyland A., Borland R., Yong H. H. et al. Electronic nicotine delivery systems: International Tobacco Control Four-country Survey. Am J Prev Med 2013; 44: 207–215.
40. Berg C. J., Stratton E., Schauer G. L., Lewis M., Wang Y., Windle M. et al. Perceived harm, addictiveness, and social acceptability of tobacco products and marijuana among young adults: marijuana, hookah, and electronic cigarettes win. Subst Use Misuse 2015; 50: 79–89.
41. Pepper J. K., Emery S. L., Ribisl K. M., Rini C. M., Brewer N. T. How risky is it to use e-cigarettes? Smokers’ beliefs about their health risks from using novel and traditional tobacco products. J Behav Med 2015; 38: 318–326.
42. Webb T. L., Sheeran P. Does changing behavioral intentions engender behavior change? A meta-analysis of the experimental evidence. Psychol Bull 2006; 132: 249–268.